PTC Therapeutics (PTCT) announced that the FDA accelerated approval of its gene therapy for the treatment of AADC deficiency, the first-ever ...

Key events this week, including the US CPI data and the speech by the Federal Reserve Chair, will be critical in providing ...

Joseph Schwartz, an analyst from Leerink Partners, reiterated the Hold rating on PTC Therapeutics (PTCT – Research Report). The ...

PTC projected adjusted earnings per share of 75 cents to 95 cents for the quarter, compared with analysts' estimate of $1.33. For the fiscal year 2025, PTC expects revenue to be between $2.51 billion ...

A trader wears a hat in support of Republican Donald Trump, after he won the U.S. presidential election, at the New York ...

Panellists were announced during annual conference for The Personal Travel Consultants in Partnership with Blue Bay Travel, ...

Berenberg downgraded PTC ( PTC, Financials) to hold from buy on Friday, citing a lack of stabilization in key markets that have continued to experience macroeconomic challenges, particularly aerospace ...

US-headquartered PTC, a global software company, is looking to raise its average annual investment of $70 million in India to $100 million. The company, which has partnered with ITC Infotech for ...

“A multitalented personality, the actress, producer and fashion icon henceforth embodies the audacity, grace and elegance of Dior style, a femininity constantly reinvented,” the press release ...

Read full article: SoDo residents raise concerns over proposed homeless shelter Read full article: ‘It’s my civic duty:’ A last look at long lines for early voting in Central Florida Wine ...

Potential bidders include rival design software makers such as PTC and Cadence Design Systems, the sources said. Reuters could not determine whether PTC and Cadence have approached Altair.

The therapy’s maker, PTC Therapeutics, is committed to keeping Translarna available in the meantime. “As Translarna will remain authorized in Europe pending review by the European Commission, we will ...